Buscar
Mostrando publicaciones 1-1 de 1
Early administration of aripiprazole long-acting injectable in acute inpatients with schizophrenia: a clinical report
(2021)
Fifty-one patients suffering an acute episode of schizophrenia and treated with aripiprazole long-acting injectable (ALAI) were chosen to elaborate an observational study in two in-patient units in Spain, in order to examine ...